Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03982576 · ClinicalTrials.gov registry record · NA
Innovations to Prevent Relapse Among Low-income African American Smokers
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03982576 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 18 participants.
The verdict
NCT03982576, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this research is to study a relapse prevention program for adult former smokers in Northeast Ohio. The study will also look at how different people respond to the program. Participants asked to take part in this study because they contacted the team for help remaining tobacco-free or otherwise expressed interest in the program. The study includes completing surveys and receiving text messages to help stay tobacco free.
Interventions
- OTHER Nicotine replacement therapy (NRT)
- BEHAVIORAL SmokefreeTXT
- BEHAVIORAL Path2Quit
- BEHAVIORAL Relapse prevention program
- BEHAVIORAL CS-CBT intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2019-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03982576
The ClinicalTrials.gov registry entry for NCT03982576 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Nicotine replacement therapy (NRT) is the first listed.
NCT03982576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03982576 about?
NCT03982576 is a clinical study titled "Innovations to Prevent Relapse Among Low-income African American Smokers". The purpose of this research is to study a relapse prevention program for adult former smokers in Northeast Ohio. The study will also look at how different people respond to the program. Participants asked to take part in this study because they contacted the team for help remaining tobacco-free or ...
What is the current status of trial NCT03982576?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-01-01. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT03982576?
The interventions under investigation include: Nicotine replacement therapy (NRT) (OTHER), SmokefreeTXT (BEHAVIORAL), Path2Quit (BEHAVIORAL), Relapse prevention program (BEHAVIORAL), CS-CBT intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03982576?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.